OpenAlex
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults
Work
Year: 2018
Type: article
Abstract: There is an unmet medical need for vaccines to prevent dengue. V180 is an investigational recombinant subunit vaccine that consists of truncated dengue envelope proteins (DEN-80E) for all 4 serotypes.... more
Source: Human Vaccines & Immunotherapeutics
Authors Susan B. Manoff, Michele Sausser, Amy Falk Russell, Jason Martin, David Radley +8 more
Institutions Merck & Co., Inc., Rahway, NJ, USA (United States), Linear Clinical Research
Cites: 12
Cited by: 52
Related to: 10
FWCI: 4.592
Citation percentile (by year/subfield): 92.54
Topic: Mosquito-borne diseases and control
Subfield: Public Health, Environmental and Occupational Health
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze